Literature DB >> 12062395

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets.

M L Herlocher1, J Carr, J Ives, S Elias, R Truscon, N Roberts, A S Monto.   

Abstract

A model of influenza transmission has been established in ferrets in which wild-type influenza infection in a donor ferret can be transmitted sequentially to other ferrets. We have studied the transmission in ferrets of a clinical isolate of A/Sydney/5/97 (H3N2) carrying the neuraminidase 292K mutation compared with the corresponding wild-type virus from the same subject. Donor ferrets (n=four per group) were inoculated intranasally with mutant or wild-type virus and each housed with three naïve contact ferrets. All donor ferrets inoculated with wildtype virus were productively infected and transmitted virus to all 12 contacts, who in turn had high viral titres in their nasal washes. In contrast, only two of the donor ferrets inoculated with mutant virus were productively infected. There was little or no evidence that the two infected donor animals transmitted mutant virus to their contact animals. This ferret model has demonstrated that the mutant influenza virus with lysine at position 292 of the neuraminidase is of reduced infectivity and does not transmit under conditions in which the wild-type virus with arginine at position 292 readily transmits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062395     DOI: 10.1016/s0166-3542(01)00214-5

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  72 in total

1.  The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.

Authors:  Wai Lan Wu; Siu-Ying Lau; Yixin Chen; Genyan Wang; Bobo Wing-Yee Mok; Xi Wen; Pui Wang; Wenjun Song; Tianwei Lin; Kwok-Hung Chan; Kwok-Yung Yuen; Honglin Chen
Journal:  Antiviral Res       Date:  2011-11-25       Impact factor: 5.970

2.  The effect of population structure on the emergence of drug resistance during influenza pandemics.

Authors:  Florence Débarre; Sebastian Bonhoeffer; Roland R Regoes
Journal:  J R Soc Interface       Date:  2007-10-22       Impact factor: 4.118

3.  The R292K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A/Shanghai/1/2013 (H7N9) influenza virus in ferrets.

Authors:  Hui-Ling Yen; Jie Zhou; Ka-Tim Choy; Sin Fun Sia; Ooiean Teng; Iris H Ng; Vicky J Fang; Yunwen Hu; Wei Wang; Benjamin J Cowling; John M Nicholls; Yi Guan; Joseph Sriyal Malik Peiris
Journal:  J Infect Dis       Date:  2014-06-20       Impact factor: 5.226

4.  The global spread of drug-resistant influenza.

Authors:  Dennis L Chao; Jesse D Bloom; Beth F Kochin; Rustom Antia; Ira M Longini
Journal:  J R Soc Interface       Date:  2011-08-24       Impact factor: 4.118

5.  Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.

Authors:  Andrew J Burnham; Tatiana Baranovich; Bindumadhav M Marathe; Jianling Armstrong; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

6.  Analysis of oseltamivir resistance substitutions in influenza virus glycoprotein neuraminidase using a lentivirus-based surrogate assay system.

Authors:  Jennifer Tisoncik-Go; Katie S Cordero; Lijun Rong
Journal:  Virol Sin       Date:  2013-02-06       Impact factor: 4.327

7.  Effect of oseltamivir carboxylate consumption on emergence of drug-resistant H5N2 avian influenza virus in Mallard ducks.

Authors:  Jenna E Achenbach; Richard A Bowen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

Review 8.  Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.

Authors:  Regina Dutkowski
Journal:  J Antimicrob Chemother       Date:  2010-04       Impact factor: 5.790

9.  Antiviral resistance during pandemic influenza: implications for stockpiling and drug use.

Authors:  Julien Arino; Christopher S Bowman; Seyed M Moghadas
Journal:  BMC Infect Dis       Date:  2009-01-22       Impact factor: 3.090

10.  Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.

Authors:  Siri H Hauge; Susanne Dudman; Katrine Borgen; Angie Lackenby; Olav Hungnes
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.